

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 6.79071742 |
| 2 | central nervous system myelination (GO:0022010) | 6.79071742 |
| 3 | fatty acid elongation (GO:0030497) | 4.92853226 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.48492936 |
| 5 | protein maturation by protein folding (GO:0022417) | 4.33244707 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.16897127 |
| 7 | proteasome assembly (GO:0043248) | 3.92373368 |
| 8 | response to methylmercury (GO:0051597) | 3.75587733 |
| 9 | myelination (GO:0042552) | 3.72927252 |
| 10 | axon ensheathment (GO:0008366) | 3.70057140 |
| 11 | ensheathment of neurons (GO:0007272) | 3.70057140 |
| 12 | viral transcription (GO:0019083) | 3.68961341 |
| 13 | chaperone-mediated protein transport (GO:0072321) | 3.62891356 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 3.61197470 |
| 15 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.61177598 |
| 16 | COPI coating of Golgi vesicle (GO:0048205) | 3.59644334 |
| 17 | Golgi transport vesicle coating (GO:0048200) | 3.59644334 |
| 18 | amyloid precursor protein metabolic process (GO:0042982) | 3.56573865 |
| 19 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.54070846 |
| 20 | translational termination (GO:0006415) | 3.50326801 |
| 21 | membrane raft organization (GO:0031579) | 3.48494262 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 3.48265770 |
| 23 | protein targeting to ER (GO:0045047) | 3.45588850 |
| 24 | ribosomal large subunit biogenesis (GO:0042273) | 3.41711163 |
| 25 | sterol biosynthetic process (GO:0016126) | 3.34486057 |
| 26 | protein localization to endoplasmic reticulum (GO:0070972) | 3.34132259 |
| 27 | protein retention in ER lumen (GO:0006621) | 3.32169592 |
| 28 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.30418214 |
| 29 | ribosomal small subunit assembly (GO:0000028) | 3.28526103 |
| 30 | type B pancreatic cell proliferation (GO:0044342) | 3.24939818 |
| 31 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.17037309 |
| 32 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.15823718 |
| 33 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.07843416 |
| 34 | translational elongation (GO:0006414) | 3.07811840 |
| 35 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06216450 |
| 36 | maturation of SSU-rRNA (GO:0030490) | 3.05816952 |
| 37 | amyloid precursor protein catabolic process (GO:0042987) | 3.02670322 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.02582375 |
| 39 | myelin maintenance (GO:0043217) | 2.96750155 |
| 40 | activated T cell proliferation (GO:0050798) | 2.95961300 |
| 41 | regulation of lipoprotein metabolic process (GO:0050746) | 2.95242891 |
| 42 | isoprenoid biosynthetic process (GO:0008299) | 2.91269000 |
| 43 | negative regulation of protein localization to cell surface (GO:2000009) | 2.91087123 |
| 44 | viral life cycle (GO:0019058) | 2.90822865 |
| 45 | ventricular cardiac muscle cell development (GO:0055015) | 2.88905174 |
| 46 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.88664876 |
| 47 | regulation of T cell migration (GO:2000404) | 2.87860697 |
| 48 | response to lipoprotein particle (GO:0055094) | 2.86249118 |
| 49 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.85151428 |
| 50 | GDP-mannose metabolic process (GO:0019673) | 2.84905414 |
| 51 | muscle cell migration (GO:0014812) | 2.83065865 |
| 52 | sequestering of actin monomers (GO:0042989) | 2.82456776 |
| 53 | translation (GO:0006412) | 2.79493932 |
| 54 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.78926186 |
| 55 | GPI anchor biosynthetic process (GO:0006506) | 2.78539213 |
| 56 | translational initiation (GO:0006413) | 2.78463741 |
| 57 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.77997299 |
| 58 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77883221 |
| 59 | protein neddylation (GO:0045116) | 2.76178595 |
| 60 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.76077738 |
| 61 | cellular protein complex disassembly (GO:0043624) | 2.74292382 |
| 62 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.73862711 |
| 63 | protein targeting to mitochondrion (GO:0006626) | 2.72082217 |
| 64 | extracellular fibril organization (GO:0043206) | 2.71341300 |
| 65 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.68174754 |
| 66 | protein targeting to membrane (GO:0006612) | 2.66911063 |
| 67 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.66442980 |
| 68 | regulation of lymphocyte migration (GO:2000401) | 2.66145487 |
| 69 | regulation of mitochondrial translation (GO:0070129) | 2.65418736 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 2.65299426 |
| 71 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.64261421 |
| 72 | negative regulation of ligase activity (GO:0051352) | 2.64261421 |
| 73 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.64211408 |
| 74 | negative regulation of chemokine production (GO:0032682) | 2.63473657 |
| 75 | formation of translation preinitiation complex (GO:0001731) | 2.60872309 |
| 76 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.59536620 |
| 77 | positive regulation of interleukin-17 production (GO:0032740) | 2.58598442 |
| 78 | neutrophil activation (GO:0042119) | 2.58342821 |
| 79 | respiratory burst (GO:0045730) | 2.56087816 |
| 80 | monocyte chemotaxis (GO:0002548) | 2.55523927 |
| 81 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.54776800 |
| 82 | creatine metabolic process (GO:0006600) | 2.52403810 |
| 83 | enteric nervous system development (GO:0048484) | 2.51485672 |
| 84 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.51359429 |
| 85 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.50963169 |
| 86 | signal peptide processing (GO:0006465) | 2.50682857 |
| 87 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.49271385 |
| 88 | amino acid import (GO:0043090) | 2.49160633 |
| 89 | establishment of protein localization to mitochondrion (GO:0072655) | 2.49011099 |
| 90 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.48060474 |
| 91 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.47979381 |
| 92 | establishment of integrated proviral latency (GO:0075713) | 2.47535182 |
| 93 | hemidesmosome assembly (GO:0031581) | 2.47215865 |
| 94 | peptidyl-proline hydroxylation (GO:0019511) | 2.47045754 |
| 95 | skin morphogenesis (GO:0043589) | 2.46249859 |
| 96 | L-amino acid import (GO:0043092) | 2.46231405 |
| 97 | cellular copper ion homeostasis (GO:0006878) | 2.45946786 |
| 98 | galactose catabolic process (GO:0019388) | 2.45450753 |
| 99 | granulocyte activation (GO:0036230) | 2.45325768 |
| 100 | 4-hydroxyproline metabolic process (GO:0019471) | 2.45064569 |
| 101 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.44864660 |
| 102 | desmosome organization (GO:0002934) | 2.44640527 |
| 103 | response to interferon-beta (GO:0035456) | 2.44165973 |
| 104 | phagocytosis, engulfment (GO:0006911) | 2.44094894 |
| 105 | axon development (GO:0061564) | 2.42971494 |
| 106 | regulation of metalloenzyme activity (GO:0048552) | 2.42682021 |
| 107 | positive regulation of actin filament depolymerization (GO:0030836) | 2.42121557 |
| 108 | leukocyte aggregation (GO:0070486) | 2.41632420 |
| 109 | protein localization to mitochondrion (GO:0070585) | 2.41053945 |
| 110 | mitotic nuclear envelope reassembly (GO:0007084) | 2.40369027 |
| 111 | nuclear envelope reassembly (GO:0031468) | 2.40369027 |
| 112 | hydrogen peroxide catabolic process (GO:0042744) | 2.40363001 |
| 113 | negative regulation of neurotransmitter transport (GO:0051589) | 2.39761482 |
| 114 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.39327970 |
| 115 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.38777186 |
| 116 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.38507228 |
| 117 | regulation of collateral sprouting (GO:0048670) | 2.38398673 |
| 118 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.37900736 |
| 119 | GPI anchor metabolic process (GO:0006505) | 2.37686037 |
| 120 | T cell migration (GO:0072678) | 2.36995413 |
| 121 | endothelial cell morphogenesis (GO:0001886) | 2.36474853 |
| 122 | galactose metabolic process (GO:0006012) | 2.35924302 |
| 123 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.34996568 |
| 124 | response to redox state (GO:0051775) | 2.34474786 |
| 125 | protein heterotetramerization (GO:0051290) | 2.34394260 |
| 126 | T-helper 1 type immune response (GO:0042088) | 2.33619479 |
| 127 | establishment of viral latency (GO:0019043) | 2.33153472 |
| 128 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.32079012 |
| 129 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.32079012 |
| 130 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.31934259 |
| 131 | regulation of interleukin-17 production (GO:0032660) | 2.30306379 |
| 132 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.29765418 |
| 133 | regulation of monocyte chemotaxis (GO:0090025) | 2.29544831 |
| 134 | tissue regeneration (GO:0042246) | 2.29431209 |
| 135 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.27658893 |
| 136 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.27658893 |
| 137 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.27658893 |
| 138 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.26957601 |
| 139 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.25733586 |
| 140 | termination of RNA polymerase III transcription (GO:0006386) | 2.25733586 |
| 141 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.24520333 |
| 142 | dermatan sulfate biosynthetic process (GO:0030208) | 2.24347420 |
| 143 | eosinophil chemotaxis (GO:0048245) | 2.24306700 |
| 144 | protein complex disassembly (GO:0043241) | 2.24080706 |
| 145 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.23995824 |
| 146 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.23995824 |
| 147 | respiratory electron transport chain (GO:0022904) | 2.23961727 |
| 148 | positive regulation of glial cell differentiation (GO:0045687) | 2.23384509 |
| 149 | negative regulation of acute inflammatory response (GO:0002674) | 2.23246596 |
| 150 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.23148405 |
| 151 | cellular component biogenesis (GO:0044085) | 2.23069120 |
| 152 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.22331890 |
| 153 | establishment of protein localization to membrane (GO:0090150) | 2.21488954 |
| 154 | positive regulation of gliogenesis (GO:0014015) | 2.21422131 |
| 155 | tricarboxylic acid cycle (GO:0006099) | 2.20840333 |
| 156 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.20821057 |
| 157 | electron transport chain (GO:0022900) | 2.20595426 |
| 158 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.20504023 |
| 159 | L-phenylalanine metabolic process (GO:0006558) | 2.20504023 |
| 160 | nucleotide transmembrane transport (GO:1901679) | 2.20481190 |
| 161 | positive regulation of T cell migration (GO:2000406) | 2.20428795 |
| 162 | positive regulation of lymphocyte migration (GO:2000403) | 2.20071640 |
| 163 | positive regulation of astrocyte differentiation (GO:0048711) | 2.19569642 |
| 164 | photoreceptor cell differentiation (GO:0046530) | 2.19423931 |
| 165 | eye photoreceptor cell differentiation (GO:0001754) | 2.19423931 |
| 166 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.18717115 |
| 167 | removal of superoxide radicals (GO:0019430) | 2.17862074 |
| 168 | cellular response to superoxide (GO:0071451) | 2.17862074 |
| 169 | cellular response to oxygen radical (GO:0071450) | 2.17862074 |
| 170 | astrocyte development (GO:0014002) | 2.17686380 |
| 171 | very long-chain fatty acid metabolic process (GO:0000038) | 2.17396890 |
| 172 | ribosomal small subunit biogenesis (GO:0042274) | 2.16157912 |
| 173 | oligodendrocyte differentiation (GO:0048709) | 2.15719973 |
| 174 | copper ion homeostasis (GO:0055070) | 2.15573507 |
| 175 | dermatan sulfate metabolic process (GO:0030205) | 2.15568069 |
| 176 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.15509532 |
| 177 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.14398443 |
| 178 | import into cell (GO:0098657) | 2.14188775 |
| 179 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.12448818 |
| 180 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.12302989 |
| 181 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.12302989 |
| 182 | regulation of neuron projection regeneration (GO:0070570) | 2.11766973 |
| 183 | regulation of axon regeneration (GO:0048679) | 2.11766973 |
| 184 | * mast cell activation (GO:0045576) | 2.11685129 |
| 185 | negative regulation of myoblast differentiation (GO:0045662) | 2.10717603 |
| 186 | autophagic vacuole fusion (GO:0000046) | 2.10218646 |
| 187 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.10100193 |
| 188 | ATP synthesis coupled proton transport (GO:0015986) | 2.09906980 |
| 189 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.09906980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.16058915 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.25874487 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.11096464 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.77731220 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.45379682 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19027135 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90470518 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.78767741 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.69728189 |
| 10 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.69710162 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.63229232 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.62905540 |
| 13 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.39423005 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.38199910 |
| 15 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.34492491 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.28648342 |
| 17 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.24025473 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.15110825 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14857011 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.12651271 |
| 21 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.07862064 |
| 22 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.05118373 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00772641 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00548808 |
| 25 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.99099999 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97014512 |
| 27 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.95338234 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94832371 |
| 29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93599507 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90544075 |
| 31 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88605056 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.87494559 |
| 33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.86876901 |
| 34 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.86143167 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.82897470 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82090051 |
| 37 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.81563677 |
| 38 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80083249 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78282594 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.77832436 |
| 41 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.77669571 |
| 42 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.77669571 |
| 43 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.76771758 |
| 44 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76363537 |
| 45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.73871315 |
| 46 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.73346993 |
| 47 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.71956836 |
| 48 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71889090 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.69642369 |
| 50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.69619420 |
| 51 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.69146420 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68659887 |
| 53 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.67356614 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.65491791 |
| 55 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.64921308 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63040266 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.61145628 |
| 58 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59518803 |
| 59 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.57768790 |
| 60 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.57709925 |
| 61 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.56855700 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.56834997 |
| 63 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56630949 |
| 64 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.55827659 |
| 65 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.55728472 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.54887388 |
| 67 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54823491 |
| 68 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54255081 |
| 69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.53099216 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.52869536 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50998034 |
| 72 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50706413 |
| 73 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49617056 |
| 74 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47918165 |
| 75 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47256174 |
| 76 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.46666927 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46390141 |
| 78 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.41754427 |
| 79 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.38794365 |
| 80 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.37638052 |
| 81 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.37410291 |
| 82 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36993920 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.36782478 |
| 84 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32973049 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32185603 |
| 86 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.32141143 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.31998731 |
| 88 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.31975359 |
| 89 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.31492152 |
| 90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30772174 |
| 91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30292258 |
| 92 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.29799384 |
| 93 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28354907 |
| 94 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28143539 |
| 95 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.27688345 |
| 96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27520638 |
| 97 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.26895432 |
| 98 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25833614 |
| 99 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25138639 |
| 100 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.23809321 |
| 101 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.22959973 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.21448650 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.20722874 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20187782 |
| 105 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.19510610 |
| 106 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.19372964 |
| 107 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19304875 |
| 108 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19188080 |
| 109 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.18315116 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.18131688 |
| 111 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.18131688 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17447850 |
| 113 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16747123 |
| 114 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.14603295 |
| 115 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13807302 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13227540 |
| 117 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13049541 |
| 118 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12847861 |
| 119 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.11966532 |
| 120 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10810373 |
| 121 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.10730277 |
| 122 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09310971 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09286581 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.09174717 |
| 125 | * WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.07378370 |
| 126 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.06937467 |
| 127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06767350 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06670611 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06652322 |
| 130 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.06458810 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.06386842 |
| 132 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05305666 |
| 133 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.04815111 |
| 134 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04390136 |
| 135 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.03269031 |
| 136 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.01439672 |
| 137 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01060149 |
| 138 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.00339099 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99956119 |
| 140 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99859482 |
| 141 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.98993140 |
| 142 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.98094135 |
| 143 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.97761112 |
| 144 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.95994557 |
| 145 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.93063917 |
| 146 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92587755 |
| 147 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91826379 |
| 148 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91426041 |
| 149 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91409676 |
| 150 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.91150563 |
| 151 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91139626 |
| 152 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.90645354 |
| 153 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89787661 |
| 154 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88056725 |
| 155 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86754751 |
| 156 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.86738486 |
| 157 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.86379596 |
| 158 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86266070 |
| 159 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84972149 |
| 160 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.84877833 |
| 161 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.83968458 |
| 162 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83079582 |
| 163 | MYB_26560356_Chip-Seq_TH2_Human | 0.82179400 |
| 164 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.81837268 |
| 165 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81806262 |
| 166 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.81537080 |
| 167 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.81537080 |
| 168 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.81537080 |
| 169 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81110077 |
| 170 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.80867734 |
| 171 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80789283 |
| 172 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.80728351 |
| 173 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.80483792 |
| 174 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.79767700 |
| 175 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79561662 |
| 176 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.79002737 |
| 177 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76383726 |
| 178 | GATA3_26560356_Chip-Seq_TH2_Human | 0.75809124 |
| 179 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.75508675 |
| 180 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75495765 |
| 181 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74969426 |
| 182 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74441961 |
| 183 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74239105 |
| 184 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.74157498 |
| 185 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.74157498 |
| 186 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73447211 |
| 187 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.72867456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010030_abnormal_orbit_morphology | 4.19570133 |
| 2 | MP0000920_abnormal_myelination | 3.80091233 |
| 3 | MP0003724_increased_susceptibility_to | 3.51176338 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.00127726 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 2.89529233 |
| 6 | MP0003136_yellow_coat_color | 2.87066320 |
| 7 | MP0006082_CNS_inflammation | 2.67124719 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.62701233 |
| 9 | MP0009785_altered_susceptibility_to | 2.62080365 |
| 10 | MP0005257_abnormal_intraocular_pressure | 2.48770702 |
| 11 | MP0003690_abnormal_glial_cell | 2.34181709 |
| 12 | MP0003950_abnormal_plasma_membrane | 2.29728119 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.28607328 |
| 14 | MP0003941_abnormal_skin_development | 2.28316167 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.27980831 |
| 16 | MP0005275_abnormal_skin_tensile | 2.26979212 |
| 17 | MP0005503_abnormal_tendon_morphology | 2.25809007 |
| 18 | MP0005671_abnormal_response_to | 2.20724370 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 2.20516890 |
| 20 | MP0002419_abnormal_innate_immunity | 2.11092840 |
| 21 | MP0005025_abnormal_response_to | 2.04988249 |
| 22 | MP0005171_absent_coat_pigmentation | 2.03841904 |
| 23 | MP0005409_darkened_coat_color | 2.00854297 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.99422449 |
| 25 | MP0000685_abnormal_immune_system | 1.99282993 |
| 26 | MP0000372_irregular_coat_pigmentation | 1.96190920 |
| 27 | MP0004381_abnormal_hair_follicle | 1.91442528 |
| 28 | MP0009379_abnormal_foot_pigmentation | 1.87664643 |
| 29 | MP0005387_immune_system_phenotype | 1.87604485 |
| 30 | MP0001790_abnormal_immune_system | 1.87604485 |
| 31 | MP0003186_abnormal_redox_activity | 1.85879956 |
| 32 | MP0000751_myopathy | 1.77609196 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 1.75869506 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.72514630 |
| 35 | MP0004742_abnormal_vestibular_system | 1.70612292 |
| 36 | MP0000762_abnormal_tongue_morphology | 1.69430403 |
| 37 | MP0003436_decreased_susceptibility_to | 1.67546795 |
| 38 | MP0002723_abnormal_immune_serum | 1.66626042 |
| 39 | MP0001905_abnormal_dopamine_level | 1.65916740 |
| 40 | MP0002009_preneoplasia | 1.64565546 |
| 41 | MP0002060_abnormal_skin_morphology | 1.64554666 |
| 42 | MP0001299_abnormal_eye_distance/ | 1.63422398 |
| 43 | MP0005023_abnormal_wound_healing | 1.57228255 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.57107927 |
| 45 | MP0010368_abnormal_lymphatic_system | 1.54062424 |
| 46 | MP0000343_altered_response_to | 1.51957044 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.51896295 |
| 48 | MP0005408_hypopigmentation | 1.48039086 |
| 49 | MP0002405_respiratory_system_inflammati | 1.47598135 |
| 50 | MP0009053_abnormal_anal_canal | 1.47439957 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.47154321 |
| 52 | MP0000750_abnormal_muscle_regeneration | 1.46518666 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.46412582 |
| 54 | MP0001800_abnormal_humoral_immune | 1.46111407 |
| 55 | MP0001819_abnormal_immune_cell | 1.44902057 |
| 56 | MP0001851_eye_inflammation | 1.43320327 |
| 57 | MP0005670_abnormal_white_adipose | 1.43136326 |
| 58 | MP0002933_joint_inflammation | 1.42224855 |
| 59 | MP0001533_abnormal_skeleton_physiology | 1.40478550 |
| 60 | MP0000537_abnormal_urethra_morphology | 1.40395338 |
| 61 | MP0005164_abnormal_response_to | 1.40378161 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.39629924 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.39425582 |
| 64 | MP0002006_tumorigenesis | 1.37029251 |
| 65 | MP0002796_impaired_skin_barrier | 1.36259078 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.33183947 |
| 67 | MP0005508_abnormal_skeleton_morphology | 1.30500314 |
| 68 | MP0002877_abnormal_melanocyte_morpholog | 1.29686984 |
| 69 | MP0003123_paternal_imprinting | 1.28702639 |
| 70 | MP0004233_abnormal_muscle_weight | 1.26280019 |
| 71 | MP0005501_abnormal_skin_physiology | 1.25982328 |
| 72 | MP0003279_aneurysm | 1.24204139 |
| 73 | MP0003942_abnormal_urinary_system | 1.21395632 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.17977687 |
| 75 | MP0004957_abnormal_blastocyst_morpholog | 1.17104259 |
| 76 | MP0003634_abnormal_glial_cell | 1.16976098 |
| 77 | MP0004858_abnormal_nervous_system | 1.16212415 |
| 78 | MP0005165_increased_susceptibility_to | 1.15520028 |
| 79 | MP0001853_heart_inflammation | 1.14495609 |
| 80 | MP0003011_delayed_dark_adaptation | 1.13325620 |
| 81 | MP0009764_decreased_sensitivity_to | 1.13082912 |
| 82 | MP0005330_cardiomyopathy | 1.11677935 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.11079460 |
| 84 | MP0001243_abnormal_dermal_layer | 1.11000866 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 1.10891601 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.10413133 |
| 87 | MP0001542_abnormal_bone_strength | 1.09858644 |
| 88 | MP0003385_abnormal_body_wall | 1.07912296 |
| 89 | MP0003763_abnormal_thymus_physiology | 1.07497853 |
| 90 | MP0009250_abnormal_appendicular_skeleto | 1.07453683 |
| 91 | MP0003633_abnormal_nervous_system | 1.05242800 |
| 92 | MP0003075_altered_response_to | 1.05000679 |
| 93 | MP0002938_white_spotting | 1.04329299 |
| 94 | MP0008932_abnormal_embryonic_tissue | 1.04019781 |
| 95 | MP0001958_emphysema | 1.03935760 |
| 96 | MP0004134_abnormal_chest_morphology | 1.02797228 |
| 97 | MP0000534_abnormal_ureter_morphology | 1.02680742 |
| 98 | MP0003329_amyloid_beta_deposits | 1.02212902 |
| 99 | MP0000647_abnormal_sebaceous_gland | 1.02083656 |
| 100 | MP0004272_abnormal_basement_membrane | 1.01821707 |
| 101 | MP0002108_abnormal_muscle_morphology | 1.00671913 |
| 102 | MP0001986_abnormal_taste_sensitivity | 1.00453754 |
| 103 | MP0000249_abnormal_blood_vessel | 0.99609618 |
| 104 | MP0000604_amyloidosis | 0.98618890 |
| 105 | MP0000467_abnormal_esophagus_morphology | 0.97229846 |
| 106 | MP0006054_spinal_hemorrhage | 0.96630701 |
| 107 | MP0008469_abnormal_protein_level | 0.96525926 |
| 108 | MP0001845_abnormal_inflammatory_respons | 0.96435724 |
| 109 | MP0010771_integument_phenotype | 0.96279265 |
| 110 | MP0005197_abnormal_uvea_morphology | 0.95944233 |
| 111 | MP0003315_abnormal_perineum_morphology | 0.95690021 |
| 112 | MP0001849_ear_inflammation | 0.95652279 |
| 113 | MP0004510_myositis | 0.95433722 |
| 114 | MP0009384_cardiac_valve_regurgitation | 0.94567025 |
| 115 | MP0003806_abnormal_nucleotide_metabolis | 0.94496697 |
| 116 | MP0004883_abnormal_blood_vessel | 0.91984646 |
| 117 | MP0002697_abnormal_eye_size | 0.91865053 |
| 118 | MP0005310_abnormal_salivary_gland | 0.91788647 |
| 119 | MP0009840_abnormal_foam_cell | 0.91463526 |
| 120 | MP0000716_abnormal_immune_system | 0.89640615 |
| 121 | MP0000733_abnormal_muscle_development | 0.89557666 |
| 122 | MP0010155_abnormal_intestine_physiology | 0.89179787 |
| 123 | MP0003448_altered_tumor_morphology | 0.88933791 |
| 124 | MP0001881_abnormal_mammary_gland | 0.87228676 |
| 125 | MP0008260_abnormal_autophagy | 0.87063425 |
| 126 | MP0000749_muscle_degeneration | 0.86872429 |
| 127 | MP0000767_abnormal_smooth_muscle | 0.86450050 |
| 128 | MP0002163_abnormal_gland_morphology | 0.85595740 |
| 129 | MP0004142_abnormal_muscle_tone | 0.85075503 |
| 130 | MP0002132_abnormal_respiratory_system | 0.84314287 |
| 131 | MP0009697_abnormal_copulation | 0.83977170 |
| 132 | MP0002254_reproductive_system_inflammat | 0.82703910 |
| 133 | MP0003828_pulmonary_edema | 0.82480865 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.82247360 |
| 135 | MP0003631_nervous_system_phenotype | 0.80757021 |
| 136 | MP0005360_urolithiasis | 0.80624544 |
| 137 | MP0004147_increased_porphyrin_level | 0.80087886 |
| 138 | MP0002896_abnormal_bone_mineralization | 0.79788304 |
| 139 | MP0002233_abnormal_nose_morphology | 0.79781931 |
| 140 | MP0003786_premature_aging | 0.79021690 |
| 141 | MP0000579_abnormal_nail_morphology | 0.78521276 |
| 142 | MP0005623_abnormal_meninges_morphology | 0.77686662 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.77192074 |
| 144 | MP0000163_abnormal_cartilage_morphology | 0.77130612 |
| 145 | MP0000358_abnormal_cell_content/ | 0.76795153 |
| 146 | MP0003656_abnormal_erythrocyte_physiolo | 0.76361226 |
| 147 | MP0003755_abnormal_palate_morphology | 0.76020726 |
| 148 | MP0000627_abnormal_mammary_gland | 0.75778595 |
| 149 | MP0005083_abnormal_biliary_tract | 0.75472564 |
| 150 | MP0005410_abnormal_fertilization | 0.75465019 |
| 151 | MP0000383_abnormal_hair_follicle | 0.75298723 |
| 152 | MP0002282_abnormal_trachea_morphology | 0.75261541 |
| 153 | MP0004264_abnormal_extraembryonic_tissu | 0.74826542 |
| 154 | MP0001346_abnormal_lacrimal_gland | 0.74301473 |
| 155 | MP0009765_abnormal_xenobiotic_induced | 0.74300088 |
| 156 | MP0009763_increased_sensitivity_to | 0.74171980 |
| 157 | MP0004947_skin_inflammation | 0.73775758 |
| 158 | MP0004019_abnormal_vitamin_homeostasis | 0.73592039 |
| 159 | MP0005193_abnormal_anterior_eye | 0.73401778 |
| 160 | MP0003195_calcinosis | 0.72429044 |
| 161 | MP0010678_abnormal_skin_adnexa | 0.72247565 |
| 162 | MP0002090_abnormal_vision | 0.72137408 |
| 163 | MP0000747_muscle_weakness | 0.71971846 |
| 164 | MP0002932_abnormal_joint_morphology | 0.71678090 |
| 165 | MP0005379_endocrine/exocrine_gland_phen | 0.69992024 |
| 166 | MP0003937_abnormal_limbs/digits/tail_de | 0.69327723 |
| 167 | MP0001293_anophthalmia | 0.69244793 |
| 168 | MP0006138_congestive_heart_failure | 0.68498836 |
| 169 | MP0000462_abnormal_digestive_system | 0.67273947 |
| 170 | MP0000049_abnormal_middle_ear | 0.67216379 |
| 171 | MP0006036_abnormal_mitochondrial_physio | 0.66792141 |
| 172 | MP0002876_abnormal_thyroid_physiology | 0.66291670 |
| 173 | MP0001216_abnormal_epidermal_layer | 0.64773794 |
| 174 | MP0002085_abnormal_embryonic_tissue | 0.62966516 |
| 175 | MP0002972_abnormal_cardiac_muscle | 0.61701357 |
| 176 | MP0004087_abnormal_muscle_fiber | 0.61176419 |
| 177 | MP0003936_abnormal_reproductive_system | 0.59956396 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 5.07386394 |
| 2 | Parakeratosis (HP:0001036) | 4.44236052 |
| 3 | Protrusio acetabuli (HP:0003179) | 4.15591197 |
| 4 | Neurofibrillary tangles (HP:0002185) | 3.94211828 |
| 5 | Axonal loss (HP:0003447) | 3.75341624 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.63778047 |
| 7 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.55701307 |
| 8 | Renal Fanconi syndrome (HP:0001994) | 3.39389002 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.36283861 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.33478696 |
| 11 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.27090301 |
| 12 | Peripheral hypomyelination (HP:0007182) | 3.27043988 |
| 13 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.25713031 |
| 14 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.25713031 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.24839710 |
| 16 | Stomatitis (HP:0010280) | 3.17380114 |
| 17 | Distal lower limb muscle weakness (HP:0009053) | 3.11513917 |
| 18 | Abnormality of macrophages (HP:0004311) | 3.11031388 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 3.07555457 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.01006526 |
| 21 | Increased hepatocellular lipid droplets (HP:0006565) | 2.87464460 |
| 22 | Cerebral hemorrhage (HP:0001342) | 2.86716356 |
| 23 | Atrophic scars (HP:0001075) | 2.82090262 |
| 24 | Hepatosplenomegaly (HP:0001433) | 2.79141670 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 2.77111682 |
| 26 | Patchy hypopigmentation of hair (HP:0011365) | 2.76362901 |
| 27 | Abnormality of the umbilical cord (HP:0010881) | 2.74658676 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73822811 |
| 29 | Cervical subluxation (HP:0003308) | 2.65796929 |
| 30 | Recurrent skin infections (HP:0001581) | 2.65399088 |
| 31 | Lipid accumulation in hepatocytes (HP:0006561) | 2.63284860 |
| 32 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.63159904 |
| 33 | Mitochondrial inheritance (HP:0001427) | 2.61345341 |
| 34 | Short nail (HP:0001799) | 2.57275285 |
| 35 | Purpura (HP:0000979) | 2.56306168 |
| 36 | Hypoalphalipoproteinemia (HP:0003233) | 2.54990826 |
| 37 | White forelock (HP:0002211) | 2.52025393 |
| 38 | Retinal dysplasia (HP:0007973) | 2.51172042 |
| 39 | Sparse eyelashes (HP:0000653) | 2.49858061 |
| 40 | Ankle contracture (HP:0006466) | 2.44923176 |
| 41 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.44850552 |
| 42 | Spinal rigidity (HP:0003306) | 2.44682940 |
| 43 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.43367991 |
| 44 | Autoimmune hemolytic anemia (HP:0001890) | 2.43263192 |
| 45 | Obstructive lung disease (HP:0006536) | 2.42610549 |
| 46 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42610549 |
| 47 | Exertional dyspnea (HP:0002875) | 2.42377685 |
| 48 | Onion bulb formation (HP:0003383) | 2.42284839 |
| 49 | Follicular hyperkeratosis (HP:0007502) | 2.40631727 |
| 50 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.40407985 |
| 51 | Fragile skin (HP:0001030) | 2.40395508 |
| 52 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.38219249 |
| 53 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37002426 |
| 54 | Abnormality of the axillary hair (HP:0100134) | 2.36727731 |
| 55 | Abnormality of secondary sexual hair (HP:0009888) | 2.36727731 |
| 56 | Abnormality of dentin (HP:0010299) | 2.35854375 |
| 57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.35164881 |
| 58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.35164881 |
| 59 | Trismus (HP:0000211) | 2.34627238 |
| 60 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34528468 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 2.34528468 |
| 62 | Spontaneous hematomas (HP:0007420) | 2.34452018 |
| 63 | Cardiovascular calcification (HP:0011915) | 2.31296299 |
| 64 | Prolonged neonatal jaundice (HP:0006579) | 2.31124309 |
| 65 | Acute encephalopathy (HP:0006846) | 2.29339354 |
| 66 | Vascular tortuosity (HP:0004948) | 2.28733190 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.27093069 |
| 68 | Petechiae (HP:0000967) | 2.26890738 |
| 69 | Abnormality of glycolysis (HP:0004366) | 2.26271220 |
| 70 | Increased serum pyruvate (HP:0003542) | 2.26271220 |
| 71 | Soft skin (HP:0000977) | 2.25971775 |
| 72 | Increased IgM level (HP:0003496) | 2.25179607 |
| 73 | Leukodystrophy (HP:0002415) | 2.25099602 |
| 74 | Hypothermia (HP:0002045) | 2.23465113 |
| 75 | Generalized amyotrophy (HP:0003700) | 2.22722429 |
| 76 | Myositis (HP:0100614) | 2.22086332 |
| 77 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.19972826 |
| 78 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.19972826 |
| 79 | Single umbilical artery (HP:0001195) | 2.19972826 |
| 80 | Rough bone trabeculation (HP:0100670) | 2.19112582 |
| 81 | Progressive macrocephaly (HP:0004481) | 2.18852139 |
| 82 | 3-Methylglutaconic aciduria (HP:0003535) | 2.18762775 |
| 83 | Abnormality of renal resorption (HP:0011038) | 2.18209900 |
| 84 | Hypoplasia of the iris (HP:0007676) | 2.16067221 |
| 85 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.14789528 |
| 86 | Sensory axonal neuropathy (HP:0003390) | 2.14638590 |
| 87 | Pulmonary artery stenosis (HP:0004415) | 2.13010840 |
| 88 | Aortic dissection (HP:0002647) | 2.12271423 |
| 89 | Cerebral edema (HP:0002181) | 2.11956160 |
| 90 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11793772 |
| 91 | Abnormal delivery (HP:0001787) | 2.11049982 |
| 92 | Vascular calcification (HP:0004934) | 2.10773897 |
| 93 | Hepatocellular necrosis (HP:0001404) | 2.09857272 |
| 94 | Slow saccadic eye movements (HP:0000514) | 2.09384908 |
| 95 | Arterial tortuosity (HP:0005116) | 2.09079448 |
| 96 | Glucose intolerance (HP:0000833) | 2.06051739 |
| 97 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.03129529 |
| 98 | Vasculitis (HP:0002633) | 2.02824735 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.02713788 |
| 100 | Concave nail (HP:0001598) | 2.02695571 |
| 101 | Spinal cord compression (HP:0002176) | 2.02503809 |
| 102 | Elbow flexion contracture (HP:0002987) | 2.02464908 |
| 103 | Hepatic necrosis (HP:0002605) | 2.02248587 |
| 104 | Partial duplication of thumb phalanx (HP:0009944) | 2.00958598 |
| 105 | Premature skin wrinkling (HP:0100678) | 2.00650644 |
| 106 | Hypergammaglobulinemia (HP:0010702) | 2.00393734 |
| 107 | Abnormality of placental membranes (HP:0011409) | 1.99044413 |
| 108 | Amniotic constriction ring (HP:0009775) | 1.99044413 |
| 109 | Amyloidosis (HP:0011034) | 1.98805764 |
| 110 | Increased muscle lipid content (HP:0009058) | 1.97619446 |
| 111 | Metaphyseal dysplasia (HP:0100255) | 1.97565278 |
| 112 | Chronic otitis media (HP:0000389) | 1.97069908 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96107061 |
| 114 | Popliteal pterygium (HP:0009756) | 1.95973624 |
| 115 | Pterygium (HP:0001059) | 1.95870601 |
| 116 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93987452 |
| 117 | Exercise intolerance (HP:0003546) | 1.92846767 |
| 118 | Macrocytic anemia (HP:0001972) | 1.92686204 |
| 119 | Abnormality of T cell number (HP:0011839) | 1.91587634 |
| 120 | Abnormal hemoglobin (HP:0011902) | 1.91283784 |
| 121 | Ulnar claw (HP:0001178) | 1.91148836 |
| 122 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.90839620 |
| 123 | Retrobulbar optic neuritis (HP:0100654) | 1.90156285 |
| 124 | Optic neuritis (HP:0100653) | 1.90156285 |
| 125 | Abnormality of the corticospinal tract (HP:0002492) | 1.89717514 |
| 126 | Aortic aneurysm (HP:0004942) | 1.88507387 |
| 127 | Achilles tendon contracture (HP:0001771) | 1.88277782 |
| 128 | Type 1 muscle fiber predominance (HP:0003803) | 1.87751618 |
| 129 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.87260629 |
| 130 | Autoamputation (HP:0001218) | 1.84525403 |
| 131 | Bell-shaped thorax (HP:0001591) | 1.84367731 |
| 132 | Stridor (HP:0010307) | 1.83910346 |
| 133 | Entropion (HP:0000621) | 1.83876784 |
| 134 | Reticulocytopenia (HP:0001896) | 1.82975312 |
| 135 | Shallow orbits (HP:0000586) | 1.82687009 |
| 136 | Bladder diverticulum (HP:0000015) | 1.82305041 |
| 137 | Increased connective tissue (HP:0009025) | 1.81957156 |
| 138 | Distal upper limb amyotrophy (HP:0007149) | 1.81520882 |
| 139 | Upper limb amyotrophy (HP:0009129) | 1.81520882 |
| 140 | Orchitis (HP:0100796) | 1.81360166 |
| 141 | Microglossia (HP:0000171) | 1.81098892 |
| 142 | Wormian bones (HP:0002645) | 1.80517685 |
| 143 | Respiratory failure (HP:0002878) | 1.80457376 |
| 144 | Increased CSF lactate (HP:0002490) | 1.80207042 |
| 145 | Redundant skin (HP:0001582) | 1.79827378 |
| 146 | Spastic paraparesis (HP:0002313) | 1.79246419 |
| 147 | Type I transferrin isoform profile (HP:0003642) | 1.79047734 |
| 148 | Blue sclerae (HP:0000592) | 1.78881252 |
| 149 | Paralysis (HP:0003470) | 1.78772392 |
| 150 | Thick nail (HP:0001805) | 1.78740418 |
| 151 | Aplasia of the musculature (HP:0100854) | 1.76569096 |
| 152 | Anhidrosis (HP:0000970) | 1.76260023 |
| 153 | Hypolipoproteinemia (HP:0010981) | 1.76118701 |
| 154 | Abnormality of carpal bone ossification (HP:0006257) | 1.75936421 |
| 155 | Gastrointestinal stroma tumor (HP:0100723) | 1.75616659 |
| 156 | Abnormality of the Achilles tendon (HP:0005109) | 1.75021959 |
| 157 | Hypokalemic alkalosis (HP:0001949) | 1.73225993 |
| 158 | Facial cleft (HP:0002006) | 1.72628794 |
| 159 | Delayed cranial suture closure (HP:0000270) | 1.71483446 |
| 160 | Right ventricular cardiomyopathy (HP:0011663) | 1.71120143 |
| 161 | Testicular atrophy (HP:0000029) | 1.70760010 |
| 162 | Loss of speech (HP:0002371) | 1.70726267 |
| 163 | Peripheral demyelination (HP:0011096) | 1.70363009 |
| 164 | Partial duplication of the phalanx of hand (HP:0009999) | 1.70137115 |
| 165 | Dysostosis multiplex (HP:0000943) | 1.69914874 |
| 166 | Supranuclear gaze palsy (HP:0000605) | 1.69892103 |
| 167 | Recurrent pneumonia (HP:0006532) | 1.69149509 |
| 168 | Urticaria (HP:0001025) | 1.68318571 |
| 169 | Adrenal hypoplasia (HP:0000835) | 1.67699434 |
| 170 | Down-sloping shoulders (HP:0200021) | 1.67677999 |
| 171 | Systemic lupus erythematosus (HP:0002725) | 1.67224144 |
| 172 | Abnormal number of erythroid precursors (HP:0012131) | 1.66628629 |
| 173 | Hand muscle atrophy (HP:0009130) | 1.66359673 |
| 174 | Mediastinal lymphadenopathy (HP:0100721) | 1.66346722 |
| 175 | Renal tubular dysfunction (HP:0000124) | 1.65994085 |
| 176 | Ulnar bowing (HP:0003031) | 1.65945076 |
| 177 | Natal tooth (HP:0000695) | 1.65435237 |
| 178 | Fragile nails (HP:0001808) | 1.62162091 |
| 179 | Lactic acidosis (HP:0003128) | 1.60810888 |
| 180 | Acanthosis nigricans (HP:0000956) | 1.58381520 |
| 181 | Short clavicles (HP:0000894) | 1.57988989 |
| 182 | Hypoplastic left heart (HP:0004383) | 1.57575873 |
| 183 | Neonatal short-limb short stature (HP:0008921) | 1.56624450 |
| 184 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.54975693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST4 | 3.93287379 |
| 2 | EPHA2 | 3.81460323 |
| 3 | PBK | 3.58723473 |
| 4 | STK39 | 3.40148024 |
| 5 | EPHB1 | 3.24205893 |
| 6 | VRK2 | 2.92326254 |
| 7 | PDK2 | 2.87012391 |
| 8 | MAPKAPK5 | 2.86600647 |
| 9 | MAP3K12 | 2.70067758 |
| 10 | TESK2 | 2.62922049 |
| 11 | STK16 | 2.42019224 |
| 12 | PAK4 | 2.40911881 |
| 13 | BLK | 2.22828169 |
| 14 | NME2 | 2.19107667 |
| 15 | BUB1 | 2.09509507 |
| 16 | KDR | 1.94157788 |
| 17 | TXK | 1.93704141 |
| 18 | EPHB2 | 1.92471608 |
| 19 | PTK2 | 1.85167458 |
| 20 | OXSR1 | 1.83388241 |
| 21 | LIMK1 | 1.81757591 |
| 22 | MAP3K14 | 1.80751022 |
| 23 | NEK1 | 1.75179460 |
| 24 | GRK7 | 1.74270308 |
| 25 | FES | 1.73448888 |
| 26 | IRAK4 | 1.70467543 |
| 27 | MUSK | 1.63657837 |
| 28 | LATS2 | 1.63350283 |
| 29 | PKN1 | 1.58683506 |
| 30 | TIE1 | 1.57073564 |
| 31 | TBK1 | 1.50897270 |
| 32 | MAP4K1 | 1.49558026 |
| 33 | ADRBK2 | 1.48552369 |
| 34 | IKBKE | 1.44193118 |
| 35 | PIM2 | 1.36491331 |
| 36 | CLK1 | 1.35766364 |
| 37 | CSK | 1.34022359 |
| 38 | IKBKB | 1.32703898 |
| 39 | MAPKAPK3 | 1.31385704 |
| 40 | KIT | 1.21946474 |
| 41 | MYLK | 1.21247540 |
| 42 | TEC | 1.19756202 |
| 43 | CASK | 1.18701547 |
| 44 | ERBB4 | 1.18435312 |
| 45 | IRAK1 | 1.18063033 |
| 46 | NME1 | 1.17139945 |
| 47 | TRPM7 | 1.12563851 |
| 48 | MAPK15 | 1.11261926 |
| 49 | EIF2AK1 | 1.10726842 |
| 50 | DAPK3 | 1.09286705 |
| 51 | TRIB3 | 1.09147415 |
| 52 | TNIK | 1.08055707 |
| 53 | FGR | 1.07742243 |
| 54 | LCK | 1.07335194 |
| 55 | BTK | 1.04582845 |
| 56 | GRK1 | 1.04479056 |
| 57 | BCR | 1.04357396 |
| 58 | NTRK1 | 1.04126280 |
| 59 | MAP3K3 | 1.03709406 |
| 60 | PRKCQ | 1.02943039 |
| 61 | BRAF | 1.01541437 |
| 62 | PDGFRA | 1.01477576 |
| 63 | BMPR1B | 0.99475319 |
| 64 | JAK3 | 0.98827626 |
| 65 | LRRK2 | 0.98410468 |
| 66 | SIK1 | 0.97596523 |
| 67 | PRKG2 | 0.97274367 |
| 68 | NLK | 0.95392040 |
| 69 | BCKDK | 0.93565003 |
| 70 | RPS6KB2 | 0.93364449 |
| 71 | MATK | 0.90656480 |
| 72 | MET | 0.89906341 |
| 73 | TYK2 | 0.89757485 |
| 74 | MAP2K2 | 0.87030009 |
| 75 | PAK2 | 0.86385465 |
| 76 | CDK8 | 0.85846016 |
| 77 | MOS | 0.84685853 |
| 78 | WEE1 | 0.83856152 |
| 79 | BMPR2 | 0.83716992 |
| 80 | LYN | 0.81521531 |
| 81 | TESK1 | 0.81124161 |
| 82 | GRK5 | 0.80697138 |
| 83 | PHKG2 | 0.79852203 |
| 84 | PHKG1 | 0.79852203 |
| 85 | TYRO3 | 0.79483728 |
| 86 | ROCK2 | 0.79366374 |
| 87 | WNK4 | 0.79059470 |
| 88 | ITK | 0.78944540 |
| 89 | ZAP70 | 0.77082527 |
| 90 | CAMK2G | 0.76121161 |
| 91 | RPS6KA5 | 0.76074945 |
| 92 | BRSK1 | 0.75545591 |
| 93 | CSF1R | 0.73735379 |
| 94 | PRKCE | 0.73485568 |
| 95 | PAK1 | 0.73294905 |
| 96 | IRAK2 | 0.73209052 |
| 97 | PRKCI | 0.72876693 |
| 98 | SYK | 0.72453289 |
| 99 | FLT3 | 0.70510847 |
| 100 | NEK6 | 0.69857972 |
| 101 | DMPK | 0.69422720 |
| 102 | TGFBR2 | 0.68902793 |
| 103 | EPHA3 | 0.67493231 |
| 104 | ABL2 | 0.67257952 |
| 105 | DAPK1 | 0.65895130 |
| 106 | PRKD1 | 0.65417128 |
| 107 | AURKA | 0.64448399 |
| 108 | PDGFRB | 0.63689067 |
| 109 | TTN | 0.62611387 |
| 110 | PIK3CA | 0.61996788 |
| 111 | SCYL2 | 0.61343310 |
| 112 | AURKB | 0.61304832 |
| 113 | NUAK1 | 0.60266984 |
| 114 | HCK | 0.60150937 |
| 115 | SRPK1 | 0.59788097 |
| 116 | TTK | 0.59031824 |
| 117 | DDR2 | 0.57735608 |
| 118 | JAK1 | 0.57523407 |
| 119 | TRIM28 | 0.56496940 |
| 120 | DYRK2 | 0.54584126 |
| 121 | ILK | 0.54063743 |
| 122 | AKT2 | 0.53733087 |
| 123 | ADRBK1 | 0.53706608 |
| 124 | STK10 | 0.53171241 |
| 125 | INSR | 0.52856171 |
| 126 | SIK3 | 0.51711277 |
| 127 | PRKD3 | 0.50905354 |
| 128 | GSK3A | 0.50813755 |
| 129 | ROCK1 | 0.49582380 |
| 130 | PRKCD | 0.48546170 |
| 131 | MST1R | 0.47976098 |
| 132 | CDK7 | 0.47964417 |
| 133 | WNK1 | 0.47817017 |
| 134 | FYN | 0.47685011 |
| 135 | PLK1 | 0.46915316 |
| 136 | TLK1 | 0.45298142 |
| 137 | IRAK3 | 0.45150955 |
| 138 | MAP2K1 | 0.44907239 |
| 139 | VRK1 | 0.44581644 |
| 140 | LMTK2 | 0.44136184 |
| 141 | IGF1R | 0.44048130 |
| 142 | CAMK2D | 0.43668768 |
| 143 | MAPKAPK2 | 0.43361539 |
| 144 | STK4 | 0.43223422 |
| 145 | YES1 | 0.43146541 |
| 146 | SMG1 | 0.42725152 |
| 147 | ARAF | 0.42598541 |
| 148 | ABL1 | 0.42189705 |
| 149 | MAPK4 | 0.42082324 |
| 150 | CSNK1G3 | 0.41261937 |
| 151 | PKN2 | 0.40680684 |
| 152 | MAPK12 | 0.40260994 |
| 153 | PLK3 | 0.38037068 |
| 154 | BMX | 0.37978146 |
| 155 | STK38 | 0.33450933 |
| 156 | MAP3K8 | 0.33421552 |
| 157 | PTK6 | 0.32679981 |
| 158 | EIF2AK3 | 0.32307904 |
| 159 | CAMK2B | 0.30270852 |
| 160 | PTK2B | 0.30068803 |
| 161 | ERN1 | 0.29919549 |
| 162 | TAOK2 | 0.29508107 |
| 163 | CDK18 | 0.29436882 |
| 164 | CSNK2A2 | 0.28229026 |
| 165 | CDK11A | 0.28139818 |
| 166 | FER | 0.27973091 |
| 167 | PAK6 | 0.27505693 |
| 168 | FGFR1 | 0.27111996 |
| 169 | CSNK2A1 | 0.25817234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.68737353 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.55282693 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.43440362 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.80178427 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.66992980 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.46557067 |
| 7 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.32518916 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.27389547 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.18536551 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.12299109 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05676813 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.04132773 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95207305 |
| 14 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.86408863 |
| 15 | RNA polymerase_Homo sapiens_hsa03020 | 1.82063314 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.80724185 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.76683521 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.73293564 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.72937743 |
| 20 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72654535 |
| 21 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72249277 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.68688120 |
| 23 | Alzheimers disease_Homo sapiens_hsa05010 | 1.68286495 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68228993 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66440869 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63338670 |
| 27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61637619 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55801997 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.53389956 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.51319553 |
| 31 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.44072642 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38103770 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37887558 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.37307162 |
| 35 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.36785920 |
| 36 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36215088 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.35613914 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 1.35260199 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.35227187 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34027405 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.32698477 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.28889046 |
| 43 | DNA replication_Homo sapiens_hsa03030 | 1.28827967 |
| 44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.27292792 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.26931622 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.25576399 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.24172066 |
| 48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18947566 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.18537499 |
| 50 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.14330282 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13806162 |
| 52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.12944472 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.12737842 |
| 54 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12087826 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10885245 |
| 56 | Mismatch repair_Homo sapiens_hsa03430 | 1.10163646 |
| 57 | Phagosome_Homo sapiens_hsa04145 | 1.09626669 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 1.09267009 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07505659 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 1.07484067 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.05718636 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.05581229 |
| 63 | Huntingtons disease_Homo sapiens_hsa05016 | 1.04423277 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.03591112 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03147607 |
| 66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99738038 |
| 67 | Lysosome_Homo sapiens_hsa04142 | 0.97490128 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.96216017 |
| 69 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.91617702 |
| 70 | Base excision repair_Homo sapiens_hsa03410 | 0.90326862 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.89335794 |
| 72 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.89110795 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.88041535 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.85738414 |
| 75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85691115 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.85385018 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.85363273 |
| 78 | Tight junction_Homo sapiens_hsa04530 | 0.83456735 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82826513 |
| 80 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82178024 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81988492 |
| 82 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81522228 |
| 83 | Measles_Homo sapiens_hsa05162 | 0.81168132 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.81163164 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81161003 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.81022798 |
| 87 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79301838 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79166545 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.78616145 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78126363 |
| 91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78087094 |
| 92 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77910687 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77728924 |
| 94 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77417610 |
| 95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76790801 |
| 96 | Proteasome_Homo sapiens_hsa03050 | 0.75736130 |
| 97 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74617070 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.70762306 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70541551 |
| 100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.70465091 |
| 101 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69269818 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68677640 |
| 103 | Peroxisome_Homo sapiens_hsa04146 | 0.68188524 |
| 104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.66905946 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.65978623 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65391594 |
| 107 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65107173 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64640168 |
| 109 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64595501 |
| 110 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63939128 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.62177967 |
| 112 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61169056 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60879767 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60860925 |
| 115 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60692903 |
| 116 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59850555 |
| 117 | Homologous recombination_Homo sapiens_hsa03440 | 0.59416775 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59159715 |
| 119 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58512839 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.58407403 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58252959 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.58146427 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.56968959 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.54772480 |
| 125 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.54644709 |
| 126 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54498746 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.54262462 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53926513 |
| 129 | Spliceosome_Homo sapiens_hsa03040 | 0.53854001 |
| 130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.53522387 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53291467 |
| 132 | RNA transport_Homo sapiens_hsa03013 | 0.53195523 |
| 133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53045703 |
| 134 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52844149 |
| 135 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.52090861 |
| 136 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51820638 |
| 137 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50670707 |
| 138 | Adherens junction_Homo sapiens_hsa04520 | 0.49645305 |
| 139 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49438339 |
| 140 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48640057 |
| 141 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47898780 |
| 142 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47859995 |
| 143 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47670577 |
| 144 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.47656308 |
| 145 | Tuberculosis_Homo sapiens_hsa05152 | 0.46081830 |
| 146 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.45406073 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45350410 |
| 148 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43238183 |
| 149 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42323395 |
| 150 | Legionellosis_Homo sapiens_hsa05134 | 0.39859534 |
| 151 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39412499 |
| 152 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38584032 |
| 153 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38333027 |
| 154 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.38324557 |
| 155 | Bladder cancer_Homo sapiens_hsa05219 | 0.38311486 |
| 156 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36982699 |
| 157 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35502474 |
| 158 | Metabolic pathways_Homo sapiens_hsa01100 | 0.34899099 |
| 159 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34425833 |
| 160 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34286737 |
| 161 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.33930020 |
| 162 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.32661790 |
| 163 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.30186437 |
| 164 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30102471 |

